Incidence assays for differentiating early from established HIV infection To understand the ... Transport to laboratories in the form of dried blood spots, to preserve antibody integrity, may ...

During acute and early HIV infection, high levels of viremia generate a massive immunologic response, which in turn contributes to rapid CD4-cell depletion. Given this process, researchers have ...

The first human clinical trials testing a new strategy to protect against HIV infections have yielded promising early results ...

Worldwide, an estimated 40 million people live with HIV. Two-thirds of this group are on the African continent. In 2023, more ...

A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce ...

There are different types of tests. Some can detect HIV in your body as early as 10 days after exposure. Others may take months to show a positive result. If you think you might have HIV ...

The protective benefit of ART against viral blips was observed among patients who initiated treatment up to 2 years after HIV acquisition.

Janssen has unveiled what it calls ‘encouraging’ early results of its vaccine to prevent infection by HIV. The phase 1/2a APPROACH study is one of dozens of trials being presented at the IAS ...

Janssen has unveiled what it calls ‘encouraging’ early results of its vaccine to prevent infection by HIV. The phase 1/2a APPROACH study is one of dozens of trials being presented at the IAS ...